Nan Jing Kang Chuan Ji Pharmatech Co., Ltd. announced that it has entered into agreement with the Zhejiang Jiuzhou Pharmaceutical Co., Ltd and will raise CNY 80 million in an equity round of funding on December 31, 2021. The transaction was approved by the investor in its 14th meeting of the 7th Board of directors. The investor will hold 51% equity of the company after completion of the transaction.

The company will use CNY 1,133,200 for its registered capital and rest for capital reserve.